Orphanet continues its quest to to improve the management and treatment of genetic, auto-immune or infectious rare diseases, rare cancers, or not yet classified rare diseases.
It launched the Orphanet Journal of Rare Diseases. The editors in chief are SÃ©golÃ¨ne AymÃ©, Inserm, HÃ´pital Broussais; Bruno Dallapiccola, Istituto CSS-Mendel; and Dian Donnai,The Victoria University of Manchester.
Thank you very much in advance for your contributions to this blog (Click on login to register and post a message).
Philippe Campeau, MD
Resident in Medical Genetics at McGill University
OMMBID Blog Administrator